Provenienza dei contatti di primo grado di Roger Belusa
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Roger Belusa tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABLYNX | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Antwerp | College/University | Doctorate Degree | |
Highlight Therapeutics SL
 Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree | |
| Technical University of Denmark | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
| Belgio | 4 |
| Spagna | 3 |
| Danimarca | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
Posizioni
| Chief Tech/Sci/R&D Officer | 5 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Contatti più connessi
- Borsa valori
- Insiders
- Roger Belusa
- Connessioni Società
